As contemplated by the Sarbanes-Oxley Act of 2002, the Board of Directors' Audit Committee has established procedures for the receipt, retention and treatment of complaints regarding the Company's accounting, internal accounting controls or auditing matters.
 

Complaints may be directed to:

(210)-677-6000

OR

William Brock, Director
OncoVista Innovative Therapies, Inc.
14785 Omicron Drive, Suite 104
San Antonio TX 78245-3222